SCHEMBL1244015

SCHEMBL1244015

COC(=O)c1[nH]c2ccoc2c1I

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ HSD17B10 Q99714 4/20 0.38
▸ GAA P10253 3/20 0.38
▸ NPSR1 Q6W5P4 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ HPGD P15428 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TUBB4A P04350 3/20 0.37
▸ TUBB P07437 3/20 0.37
▸ TUBA3C P0DPH7 3/20 0.37
▸ TUBA1B P68363 3/20 0.37
▸ TUBA4A P68366 3/20 0.37
▸ TUBB4B P68371 3/20 0.37
▸ TUBB3 Q13509 3/20 0.37
▸ TUBB2A Q13885 3/20 0.37
▸ TUBB8 Q3ZCM7 3/20 0.37
▸ TUBA3E Q6PEY2 3/20 0.37
▸ TUBA1A Q71U36 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8253165 0.84 KDM4E (0.43) KDM4EALDH1A1HSD17B10GAANPSR1
SCHEMBL8225320 0.83 KDM4E (0.38) KDM4EALDH1A1HSD17B10GAANPSR1
SCHEMBL12388669 0.81 KDM4E (0.34) KDM4EALDH1A1HSD17B10GAANPSR1
SCHEMBL1244884 0.81 MAPT (0.39) KDM4EALDH1A1HSD17B10GAANPSR1
SCHEMBL1244909 0.81 CCNC (0.38) KDM4EALDH1A1HSD17B10GAANPSR1
SCHEMBL1242676 0.80 DAO (0.42) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL1244859 0.75 KDM4E (0.38) KDM4EALDH1A1HSD17B10GAANPSR1
SCHEMBL3338049 0.71 MEN1 (0.58) KDM4EALDH1A1HSD17B10GAANPSR1
SCHEMBL13484252 0.70 AHR (0.30) —
SCHEMBL30990249 0.69 TUBB4A (0.42) KDM4EALDH1A1HSD17B10GAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4626860-A1 FUSED PYRROLYL-SULFONAMIDE COMPOUNDS ReWind Therapeutics NV (BE) 2025-10-08 — — EP disclosed
WO-2024115733-A1 FUSED PYRROLYL-SULFONAMIDE COMPOUNDS REWIND THERAPEUTICS NV (BE) 2024-06-06 — — WO disclosed
US-7884124-B2 such as 2-Fluoro-4H-furo[3,2-b]pyrrole-5-carboxylate acid, used for the treatment of neuropathic pain, Alzheimer's disease, schizophrenia, ataxia and convulsions SEPRACOR INC. (US) 2011-02-08 — — US disclosed
US-7884124-B2 such as 2-Fluoro-4H-furo[3,2-b]pyrrole-5-carboxylate acid, used for the treatment of neuropathic pain, Alzheimer's disease, schizophrenia, ataxia and convulsions SEPRACOR INC. (US) 2011-02-08 — — US disclosed
US-7884124-B2 such as 2-Fluoro-4H-furo[3,2-b]pyrrole-5-carboxylate acid, used for the treatment of neuropathic pain, Alzheimer's disease, schizophrenia, ataxia and convulsions SEPRACOR INC. (US) 2011-02-08 — — US disclosed
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase SEPRACOR INC. (US) 2008-03-06 — — US disclosed
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase SEPRACOR INC. (US) 2008-03-06 — — US disclosed
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase SEPRACOR INC. (US) 2008-03-06 — — US disclosed
WO-2008005456-A2 FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-01-10 — — WO disclosed
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-01-03 — — US disclosed
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-01-03 — — US disclosed
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase DAO, DDO, AOX1 KDM4E 2644/4885ALDH1A1 866/4885HSD17B10 1387/4885
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE DAO, DDO, AOX1 KDM4E 2046/4885ALDH1A1 622/4885HSD17B10 2258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback